Taiwan FDA registration bf7cb7aa2d9eb800553fe1180aa11d19
LIAISON CMV IgG II
TW: 禮亞尚巨細胞病毒IgG檢測試劑 第二代
Taiwan·Risk Class 2·MD·DIASORIN ITALIA S.P.A.·Registered Jul 22, 2014 – Jul 22, 2024ExpiredRegistration details
- Analysis ID
- bf7cb7aa2d9eb800553fe1180aa11d19
- License Form
- Ministry of Health Medical Device Import No. 026276
- Customs Code
- DHA05602627600
Company information
- Manufacturer
- DIASORIN ITALIA S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- This product uses chemical cold light particle immunoassay (CLIA) to quantify cytomegalovirus IgG antibodies in human serum and plasma. This product should be used with a Reasan analyzer.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C3175 CMV serum reagent
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jul 22, 2014
- Expiry Date
- Jul 22, 2024
About this record
Access comprehensive regulatory information for LIAISON CMV IgG II in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bf7cb7aa2d9eb800553fe1180aa11d19 and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices